CORC

浏览/检索结果: 共32条,第1-10条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Phase III Randomized AUGMENT Study of Lenalidomide/Rituximab vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma 会议论文
作者:  Gribben, J.;  Trneny, M.;  Izutsu, K.;  Fowler, N. H.;  Hong, X.
收藏  |  浏览/下载:22/0  |  提交时间:2019/12/05
Phase III study of trastuzumab emtansine (T-DM1) vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy including trastuzumab: Primary results from KATHERINE 会议论文
作者:  Geyer, C. E., Jr.;  Huang, C-S;  Mano, M. S.;  Loibl, S.;  Mamounas, E. P.
收藏  |  浏览/下载:27/0  |  提交时间:2019/12/05
A Phase IIIb Trial of Afatinib in EGFRm plus NSCLC: Analyses of Outcomes in Patients with Brain Metastases or Dose Reductions 会议论文
作者:  Wu, Y.;  Tu, H.;  Feng, J.;  Shi, M.;  Zhao, J.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Dynamic ctDNA Monitoring Revealed Novel Resistance Mechanisms and Response Predictors of Osimertinib Treatment in East Asian NSCLC Patients 会议论文
作者:  Chan, J.;  Hu, Z.;  Ili, D.;  Chuai, S.;  Shen, W.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Dynamic ctDNA Monitoring Revealed Novel Resistance Mechanisms and Response Predictors of Osimertinib Treatment in East Asian NSCLC Patients 会议论文
作者:  Chang, J.;  Hu, Z.;  Ji, D.;  Chuai, S.;  Shen, W.
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Brain networks of cerebral metabolism and perfusion associated with cerebellar variant of multiple system atrophy: a FDG PET and ASL MRI study 会议论文
作者:  Peng, S.;  Ge, J.;  Wu, P.;  Wang, J.;  Dhawan, V.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naive Patients with EGFRm plus NSCLC: An Interim Analysis 会议论文
作者:  Wu, Y.;  Tu, H.;  Feng, J.;  Shi, M.;  Zhao, J.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
afatinib  EGFR  NSCLC  
Phase III study of trifluridine/tipiracil versus placebo in Asian patients with metastatic colorectal cancer (TERRA study): Country subgroup 会议论文
作者:  Sriuranpong, V.;  Kim, T. W.;  Shen, L.;  Xu, J.;  Pan, H.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Efficacy, safety and pharmacokinetics (PK) of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): An Asian multinational study 会议论文
作者:  Ahn, H.;  Ye, D.;  Pu, Y-S.;  Han, W.;  Xie, L-P.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
REPRODUCIBILITY OF ABNORMAL BRAIN METABOLISM ASSOCIATED WITH PROGRESSIVE SUPRANUCLEAR PALSY: NETWORK AND REGIONAL COMPARISONS BETWEEN A US AND A CHINESE COHORT 会议论文
作者:  Ge, J.;  Wu, J.;  Peng, S.;  Wu, P.;  Wang, J.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace